Drug Type Cytokines |
Synonyms Recombinant Cytokine Gene Derived Protein, 重组细胞因子基因衍生蛋白(杰华生物), Novaferon + [1] |
Target |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (12 Apr 2018), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hepatitis B | CN | 12 Apr 2018 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 3 | JP | 25 Mar 2021 | |
Colorectal Cancer | Phase 3 | CN | 20 Apr 2011 | |
Neoplasms | Phase 2 | CN | 30 Jan 2022 | |
Neoplasms | Phase 2 | CN | 30 Jan 2022 | |
Neoplasms | Phase 2 | CN | 30 Jan 2022 | |
Neuroendocrine Carcinoma | Phase 2 | CN | 09 Jul 2015 | |
Melanoma | Phase 2 | CN | 10 Aug 2011 | |
Autoimmune Diseases | Preclinical | CN | 30 Jan 2022 | |
Autoimmune Diseases | Preclinical | CN | 30 Jan 2022 | |
Autoimmune Diseases | Preclinical | CN | 30 Jan 2022 |